Assembly Biosciences, Inc. Profile Avatar - Palmy Investing

Assembly Biosciences, Inc.

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as co…

Biotechnology
US, South San Francisco [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ASMB's Analysis
CIK: 1426800 CUSIP: 045396108 ISIN: US0453962070 LEI: - UEI: -
Secondary Listings
ASMB has no secondary listings inside our databases.